Why Europe can’t access these 100 new drugs (and how to change it)
“Europe is missing too many innovations.” I had the pleasure of welcoming Pierre-Henri Belin, the Co-Founder and CEO of Xcube.Bio — an innovative company that accelerates biopharma market entry across Europe. By combining capital, deep expertise, and industry knowledge, Xcube.Bio helps mitigate risks and launch transformative solutions. Pierre-Henri is a…
























